Latest combination therapies in psoriasis: Narrative review of the literature.
biological drugs
combination therapies
psoriasis
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
29
06
2022
received:
16
05
2022
accepted:
07
08
2022
pubmed:
13
8
2022
medline:
5
10
2022
entrez:
12
8
2022
Statut:
ppublish
Résumé
Biological therapies revolutionized the treatment of many chronic inflammatory skin diseases, first of all psoriasis, thanks to their high efficacy and the reduced number of side effects. However, the use of a single biologic drug does not always provide complete control of the disease or associated comorbidities over time. The first biological drugs used for the treatment of psoriasis, tumor necrosis factor alpha inhibitors, have long been used in combination with traditional topical and systemic therapies to induce a complete remission of the disease that could not be achieved with innovative drug alone. Even with the advent of new biological therapies with more precise molecular targets, the challenge of using combination therapies remained. Psoriatic patients often have major comorbidities, such as arthritis, inflammatory bowel disease, uveitis or have other concomitant conditions such as chronic spontaneous urticaria and atopic dermatitis, which may require different biologic treatments than those indicated in psoriasis. The objective of this article is, through a comprehensive revision of the literature, to analyze in which cases the use of the combination of the latest therapies for psoriasis may be useful.
Identifiants
pubmed: 35959523
doi: 10.1111/dth.15759
pmc: PMC9786636
doi:
Substances chimiques
Biological Products
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15759Informations de copyright
© 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC.
Références
J Drugs Dermatol. 2019 Apr 01;18(4):394-396
pubmed: 31017383
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1781-5
pubmed: 25809089
Inflamm Bowel Dis. 2018 Aug 16;24(9):2086-2092
pubmed: 29718343
BioDrugs. 2019 Aug;33(4):353-356
pubmed: 31175631
J Dermatolog Treat. 2021 Jun;32(4):438-439
pubmed: 31438730
JAAD Case Rep. 2017 May 15;3(3):240-242
pubmed: 28540359
Clin Rheumatol. 2018 Oct;37(10):2741-2749
pubmed: 30056525
Dermatol Ther. 2022 Oct;35(10):e15759
pubmed: 35959523
J Drugs Dermatol. 2016 May 1;15(5):648-9
pubmed: 27168275
Eur J Dermatol. 2021 Oct 1;31(5):630-637
pubmed: 34789441
Exp Dermatol. 2017 Apr;26(4):319-324
pubmed: 27376466
Paediatr Drugs. 2020 Aug;22(4):409-416
pubmed: 32378002
J Dig Dis. 2020 May;21(5):264-271
pubmed: 32324969
J Drugs Dermatol. 2011 Apr;10(4):366-71
pubmed: 21455546
Ont Health Technol Assess Ser. 2009;9(27):1-66
pubmed: 23074532
Curr Pharm Biotechnol. 2021;22(1):7-31
pubmed: 32598253
Curr Rheumatol Rev. 2019;15(3):234-237
pubmed: 30499418
J Drugs Dermatol. 2008 Mar;7(3):245-53
pubmed: 18380206
Eur J Rheumatol. 2019 Jan;6(1):60-61
pubmed: 30071939
Int J Dermatol. 2001 Jan;40(1):64-6
pubmed: 11277960
Australas J Dermatol. 2022 Feb;63(1):e63-e66
pubmed: 34813085
JAAD Case Rep. 2019 Oct 10;5(10):928-930
pubmed: 31649982
J Dermatol. 2013 Jun;40(6):424-7
pubmed: 23414298
Expert Opin Drug Saf. 2020 Apr;19(4):489-498
pubmed: 31985309
Expert Opin Drug Metab Toxicol. 2019 Nov;15(11):913-925
pubmed: 31623470
J Drugs Dermatol. 2013 Oct;12(10):1098-102
pubmed: 24085044
Eur J Dermatol. 2011 Jul-Aug;21(4):568-72
pubmed: 21697032
Br J Dermatol. 2016 May;174(5):1145-6
pubmed: 26522308
Dermatol Ther. 2020 Jul;33(4):e13740
pubmed: 32478970
Clin Exp Dermatol. 2019 Oct;44(7):e243-e244
pubmed: 31055844
Br J Dermatol. 2002 Jan;146(1):118-21
pubmed: 11841377
Case Rep Gastrointest Med. 2018 Feb 15;2018:9679287
pubmed: 29666723
Immunotherapy. 2020 Dec;12(18):1287-1292
pubmed: 32957824
Biomedicines. 2021 Oct 21;9(11):
pubmed: 34829740
J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S55-8
pubmed: 9344186
Indian J Dermatol. 2016 Jan-Feb;61(1):118
pubmed: 26955121
G Ital Dermatol Venereol. 2018 Feb;153(1):5-10
pubmed: 27845513
J Dtsch Dermatol Ges. 2012 Nov;10(11):821-37
pubmed: 22934607
J Cutan Med Surg. 2016 Jul;20(4):313-6
pubmed: 26848145
JAAD Case Rep. 2014 Sep 19;1(1):3-4
pubmed: 27075123
Dermatol Ther. 2022 Apr;35(4):e15359
pubmed: 35138022
Ann Dermatol Venereol. 2001 Jun-Jul;128(6-7):737-45
pubmed: 11460037
Br J Dermatol. 2012 Jan;166(1):147-53
pubmed: 21910714
Am J Clin Dermatol. 2015 Aug;16(4):285-294
pubmed: 25963062